PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

PACT - Public Activities Coordination Tool

The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.

PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:

  • Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
  • Assessment of regulatory needs (ARN).
  • Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.

A summary of all the substance-specific activities can be found under ‘Details’ for each entry.

Filter the list
Latest update:
Process:

The List does not contain any Substances.
Data generation and assessment ARN Regulatory risk management
 
1,2,3,4-tetrahydronaphthalene-1-carbonitrile 611-399-1 56536-96-0 - - - - 1 - - - - Details
3-methoxy-3-methylbutan-1-ol 260-252-4 56539-66-3 - - 3 - - - - - - Details
Propane-1,2,3-triyl 3,5,5-trimethylhexanoate 260-257-1 56554-53-1 - - 1 - 1 - - - - Details
Ethylenediamine-N,N'-di(acetic acid) 227-105-6 5657-17-0 - - 1 - 1 - - - - Details
(E)-5-decenol 260-267-6 56578-18-8 - - - - - 1 - - - Details
Bicyclo[2.2.1]heptanebis(methylamine) 260-280-7 56602-77-8 - - - - 1 - - - - Details
(Z)-hexadec-11-en-1-ol 260-337-6 56683-54-6 - - - - - 1 - - - Details
4,4,13,13-tetraethoxy-3,14-dioxa-8,9-dithia-4,13-disilahexadecane 260-350-7 56706-10-6 - - 4 - - - - - - Details
[[p-(2-methoxyethyl)phenoxy]methyl]oxirane 260-353-3 56718-70-8 - - - - 1 - - - - Details
dioctyl tetrabromophthalate 701-414-0 56720-20-8 - - - - 1 - - - - Details
Dodecane-1,12-diol 227-133-9 5675-51-4 - - 1 - 1 - - - - Details
A reaction mixture containing the following components;A: Tetralithium[2(or 3), 9 (or 10), 16(or 17), 23 (or 24)-tetrakis (3-sulfonato-propylsulfonyl)phthalocyaninato]cuprate (II)B: Trilithium [3-(2-hyroxylpropylsulfamoyl) propylsulfonyl]tris (3-sulfonato-propylsulfonyl) phtalocyaninatocuprate(II)C: Dilithiumbis [3-(2-hydroxylpropylsulfamoyl)propylsulfonyl] bis (3-sulfonato-propylsulfonyl)phtalocyaninatcuprate (II)D: Lithiumtris [3-(2-hyroxylpropylsulfamoyl) propylsulfonyl](3-sulfonato-propylsulfonyl)phtalocyaninto] cuprate (II)E: Tetrakis [3-(2-hyroxypropylsulfamoyl)propylsulphonyl]phthalocyaninatocuprate (II)in the ratio A:B:C:D:Eca 32:42:21:5:<1 445-470-1 569316-88-7 - - 1 - - - - - - Details
4-(3-ethoxy-4-hydroxyphenyl)butan-2-one 933-435-8 569646-79-3 - - - - 1 - - - - Details
4-(3-éthoxy-4-hydroxyphényl)butan-2-one 810-128-6 569646-79-3 - - - - 1 - - - - Details
1-(5,5-dimethyl-1-cyclohexen-1-yl)pent-4-en-1-one 260-486-7 56973-85-4 - - - - 1 - - - - Details
1-(3,3-dimethylcyclohexyl)pent-4-en-1-one
GALBANIFF
422-330-8 56973-87-6 - - - - 1 - - - - Details
[No public or meaningful name is available] 687-590-9 56973-87-6 - - - - 1 - - - - Details
Magnesium acrylate 227-177-9 5698-98-6 - - - - 1 - - - - Details
Cetrimonium bromide 200-311-3 57-09-0 - - 1 - - - - - - Details
Palmitic acid 200-312-9 57-10-3 - - 1 - - - - - - Details
Urea 200-315-5 57-13-6 - - 2 - - - - - - Details
Fructose 200-333-3 57-48-7 - - - - 1 - - - - Details
Sucrose 200-334-9 57-50-1 - - - - 1 - - - - Details
Propane-1,2-diol 200-338-0 57-55-6 - - 1 - 1 1 - - - Details
Chlordane , pur 200-349-0 57-74-9 - - - - - - - - - Details
tolclofos-methyl (ISO); O-(2,6-dichloro-p-tolyl) O,O-dimethyl thiophosphate 260-515-3 57018-04-9 - - - - - 1 - - - Details
N-(tri(hydroxymethyl)methyl)glycine 227-193-6 5704-04-1 - - 1 - 1 - - - - Details
4-Ethylbiphenyl 679-980-2 5707-44-8 - - - - 1 - - - - Details
1,4-dimethylnaphthalene 209-335-9 571-58-4 - - - - - 1 - - - Details
Hexahydro-3-methylphthalic anhydride 260-566-1 57110-29-9 - - - - 1 - - - - Details
Aluminum zirconium chloride hydroxide 260-599-1 57158-29-9 - - 2 - - - - - - Details
[μ-[carbonato(2-)-O:O']]dihydroxydioxodizirconium 260-633-5 57219-64-4 - - - - 1 - - - - Details
Disodium 3,3'-[[1,1'-biphenyl]-4,4'-diylbis(azo)]bis(4-aminonaphthalene-1-sulphonate) 209-358-4 573-58-0 - - - - - - 1 - - Details
Dodecahydro-3,8,8,11a-tetramethyl-5H-3,5a-epoxynaphth[2,1-c]oxepin 260-686-4 57345-19-4 - - - - 1 - - - - Details
(2-{[Carboxy-(2-hydroxy-5-sulfo-phenyl)-methyl]-amino}-ethylamino)-(2-hydroxy-5-sulfo-phenyl)-acetic acid 611-514-5 57368-07-7 - - - - 1 - - - - Details
1-(2,6,6-trimethyl-3-cyclohexen-1-yl)-2-buten-1-one 260-709-8 57378-68-4 - - - - 1 - - - - Details
Magnesium neodecanoate 260-742-8 57453-97-1 - - - - 1 - - - - Details
Oxybis(methyl-2,1-ethanediyl) diacrylate 260-754-3 57472-68-1 - - 1 - 1 - - - - Details
1-[1,6-dimethyl-4-(4-methylpent-3-enyl)-3-cyclohexen-1-yl]ethan-1-one 260-772-1 57499-57-7 - - - - 1 - - - - Details
2-ethylhexyl 10-ethyl-4-[[2-[(2-ethylhexyl)oxy]-2-oxoethyl]thio]-4-methyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-828-5 57583-34-3 1 - 2 - - 1 - - - Details
2-ethylhexyl 10-ethyl-4,4-dimethyl-7-oxo-8-oxa-3,5-dithia-4-stannatetradecanoate 260-829-0 57583-35-4 - - 3 - 1 1 - - - Details
Tetraphenyl m-phenylene bis(phosphate) 260-830-6 57583-54-7 - - 1 - 1 - - - - Details
2,6-xylenol 209-400-1 576-26-1 - - 1 - - - - - - Details
Docusate sodium 209-406-4 577-11-7 - - 2 - - - - - - Details
benzyl(diethylamino)diphenylphosphonium 4-[1,1,1,3,3,3-hexafluoro-2-(4-hydroxyphenyl)propan-2-yl]phenolate 479-100-5 577705-90-9 - - - - 1 1 - - - Details
Potassium salicylate 209-421-6 578-36-9 - - - - 1 - - - - Details
2-ethylaniline 209-424-2 578-54-1 - - - - 1 - - - - Details
2-methylanisole 209-426-3 578-58-5 - - - - 1 - - - - Details
Ethyl 4-[[(methylphenylamino)methylene]amino]benzoate 260-976-0 57834-33-0 - - 1 - - - - - - Details
(±)-2-hydroxy-1,2-diphenylethan-1-one 209-441-5 579-44-2 - - - - 1 - - - - Details

Export search results to: